BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10438908)

  • 1. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation.
    Colucci F; Turner M; Schweighoffer E; Guy-Grand D; Di Bartolo V; Salcedo M; Tybulewicz VL; Di Santo JP
    J Immunol; 1999 Aug; 163(4):1769-74. PubMed ID: 10438908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new look at Syk in alpha beta and gamma delta T cell development using chimeric mice with a low competitive hematopoietic environment.
    Colucci F; Guy-Grand D; Wilson A; Turner M; Schweighoffer E; Tybulewicz VL; Di Santo JP
    J Immunol; 2000 May; 164(10):5140-5. PubMed ID: 10799872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases.
    Colucci F; Schweighoffer E; Tomasello E; Turner M; Ortaldo JR; Vivier E; Tybulewicz VL; Di Santo JP
    Nat Immunol; 2002 Mar; 3(3):288-94. PubMed ID: 11836527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.
    Pisegna S; Zingoni A; Pirozzi G; Cinque B; Cifone MG; Morrone S; Piccoli M; Frati L; Palmieri G; Santoni A
    J Immunol; 2002 Jul; 169(1):68-74. PubMed ID: 12077230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
    Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
    J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation.
    Gadue P; Stein PL
    J Immunol; 2002 Sep; 169(5):2397-406. PubMed ID: 12193707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
    Turner M; Mee PJ; Costello PS; Williams O; Price AA; Duddy LP; Furlong MT; Geahlen RL; Tybulewicz VL
    Nature; 1995 Nov; 378(6554):298-302. PubMed ID: 7477352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny.
    Gadue P; Yin L; Jain S; Stein PL
    J Immunol; 2004 May; 172(10):6093-100. PubMed ID: 15128794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
    Mason LH; Willette-Brown J; Taylor LS; McVicar DW
    J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses.
    Brumbaugh KM; Pérez-Villar JJ; Dick CJ; Schoon RA; López-Botet M; Leibson PJ
    J Immunol; 1996 Oct; 157(7):2804-12. PubMed ID: 8816383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation.
    Sedlik C; Orbach D; Veron P; Schweighoffer E; Colucci F; Gamberale R; Ioan-Facsinay A; Verbeek S; Ricciardi-Castagnoli P; Bonnerot C; Tybulewicz VL; Di Santo J; Amigorena S
    J Immunol; 2003 Jan; 170(2):846-52. PubMed ID: 12517949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
    Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
    J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
    J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.